Drug intelligence / Profile preview

Wuzhi Drop Pills

Development stage
Unknown
Lead developer
Fang Lue Pharmaceutical Company
Modality
Small Molecules
Administration
Oral
01

Overview

Wuzhi Drop Pills is a traditional Chinese medicine (TCM) preparation derived from the ethanol extract of *Schisandra sphenanthera*. It is officially approved in China for the treatment of elevated alanine aminotransferase (ALT) levels associated with chronic hepatitis and other forms of liver injury. The formulation contains dibenzocyclooctadiene lignans, such as schisandrin A, B, and C, which exhibit potent hepatoprotective and antioxidant properties. In clinical practice, Wuzhi Drop Pills is frequently utilized as an adjuvant therapy in organ transplant recipients. It acts as a significant inhibitor of the cytochrome P450 3A (CYP3A) enzyme system, which reduces the metabolism of immunosuppressants like tacrolimus and cyclosporine A, thereby increasing their blood concentrations and allowing for lower therapeutic dosing.

Brand names
Wuzhi Drop Pills
Other names
Wu Zhi Di Wan五酯滴丸Wuzhi capsulesSchisandra sphenanthera extract
02

Targets

CYP3A4 (Cytochrome P450 3A4)CYP3A5 (Cytochrome P450 family 3 subfamily A member 5)ABCB1 (P-glycoprotein)

Beyond the preview

Go deeper on Wuzhi Drop Pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuzhi Drop Pills.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call